- Home
- KURA vs CIM Comparison
KURA vs CIM Comparison
Compare KURA & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- CIM
- Stock Information
- Founded
- KURA 2014
- CIM 2007
- Country
- KURA United States
- CIM United States
- Employees
- KURA N/A
- CIM N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- CIM Real Estate Investment Trusts
- Sector
- KURA Health Care
- CIM Real Estate
- Exchange
- KURA Nasdaq
- CIM Nasdaq
- Market Cap
- KURA 793.2M
- CIM 1.2B
- IPO Year
- KURA N/A
- CIM 2007
- Fundamental
- Price
- KURA $7.26
- CIM $14.00
- Analyst Decision
- KURA Strong Buy
- CIM Hold
- Analyst Count
- KURA 11
- CIM 1
- Target Price
- KURA $27.89
- CIM $16.00
- AVG Volume (30 Days)
- KURA 1.8M
- CIM 587.7K
- Earning Date
- KURA 02-25-2025
- CIM 02-12-2025
- Dividend Yield
- KURA N/A
- CIM 10.60%
- EPS Growth
- KURA N/A
- CIM 117.60
- EPS
- KURA N/A
- CIM 3.36
- Revenue
- KURA N/A
- CIM $442,341,000.00
- Revenue This Year
- KURA N/A
- CIM N/A
- Revenue Next Year
- KURA $233.30
- CIM $11.33
- P/E Ratio
- KURA N/A
- CIM $4.16
- Revenue Growth
- KURA N/A
- CIM 44.27
- 52 Week Low
- KURA $6.98
- CIM $11.29
- 52 Week High
- KURA $24.17
- CIM $16.89
- Technical
- Relative Strength Index (RSI)
- KURA 17.38
- CIM 42.69
- Support Level
- KURA $6.98
- CIM $13.38
- Resistance Level
- KURA $8.88
- CIM $14.44
- Average True Range (ATR)
- KURA 0.33
- CIM 0.31
- MACD
- KURA 0.05
- CIM -0.02
- Stochastic Oscillator
- KURA 13.40
- CIM 57.94
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.